,outcome,arm 1,arm 2
0,intervention,induction,noninduction
0,"incidence of adverse events, fever, cytomegalovirus ( CMV ) infection, herpes simplex","11.3 %, 37.3 %","10.1 %, 19.0 %, 3.2 %, 5.7 %, 9.5 %"
0,"incidence of adverse events, cytomegalovirus ( CMV ) infection, herpes simplex",25.2 %,17.9 %
0,"incidence of adverse events, fever, cytomegalovirus ( CMV ) infection, herpes simplex, total study group",32.5 %,32.5 %
